-
Tytuł:
-
[Smoking cessation and lung cancer screening].
-
Autorzy:
-
Peiffer G; Service de pneumologie, CHR de Metz-Thionville, 1, allée du Château, 57085 Metz, France. Electronic address: .
Underner M; Unité de recherche clinique, centre hospitalier Henri-Laborit, université de Poitiers, 86021 Poitiers, France.
Perriot J; CLAT 63, dispensaire Emile-Roux, centre de tabacologie, 63100 Clermont-Ferrand, France.
Ruppert AM; Unité de tabacologie, service de pneumologie, hôpital Tenon, Assistance publique-Hôpitaux de Paris, 4, rue de la Chine, 75970 Paris cedex 20, France.
Tiotiu A; Département de pneumologie, CHRU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France.
-
Transliterated Title:
-
Sevrage tabagique et dépistage du cancer du poumon.
-
Źródło:
-
Revue des maladies respiratoires [Rev Mal Respir] 2020 Nov; Vol. 37 (9), pp. 722-734. Date of Electronic Publication: 2020 Oct 29.
-
Typ publikacji:
-
Journal Article; Review
-
Język:
-
French
-
Imprint Name(s):
-
Publication: <2009- > : Issy-les-Moulineaux Cedex, France : Elsevier-Masson
Original Publication: Paris ; New York : Masson, c1984-
-
MeSH Terms:
-
Smoking Cessation*/methods
Smoking Cessation*/statistics & numerical data
Lung Neoplasms/*diagnosis
Early Detection of Cancer/methods ; Early Detection of Cancer/statistics & numerical data ; France/epidemiology ; Humans ; Lung Neoplasms/epidemiology ; Mass Screening/methods ; Mortality ; Smokers/statistics & numerical data ; Smoking/epidemiology ; Smoking/therapy
-
Contributed Indexing:
-
Keywords: Cancer du poumon; Dépistage; Lung cancer; Motivation à l’arrêt du tabac; Screening; Sevrage tabagique; Smoking cessation; Smoking cessation strategies; Smoking motivation; Stratégies d’aide à l’arrêt
-
Entry Date(s):
-
Date Created: 20201101 Date Completed: 20201127 Latest Revision: 20201127
-
Update Code:
-
20240105
-
DOI:
-
10.1016/j.rmr.2020.09.005
-
PMID:
-
33129612
-
Several studies have shown that lung cancer screening, using annual low-dose computed tomography (CT) scan in a targeted population of smokers and ex-smokers reduces overall and lung cancer specific mortality rates. This form of screening strategy is not currently established for use in France by the French High Authority for Health. Quitting smoking is the most important measure in reducing mortality from lung cancer. The maximum benefit in reducing mortality from lung cancer should be seen through an effective combination of smoking cessation intervention and chest CT screening to identify early, curable disease. However, current data to guide clinicians in the choice of smoking cessation interventions in this specific context are limited due to the small number of randomized studies that have been carried out. The optimal approach to smoking cessation during lung cancer screening needs to be clarified by new studies comparing different motivation strategies, establishing the ideal moment to propose stopping smoking and the most effective therapies to use.
(Copyright © 2020 SPLF. Published by Elsevier Masson SAS. All rights reserved.)